Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.
Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: A pilot study.
Color-Code Agreement Among Stratus, Cirrus, and Spectralis Optical Coherence Tomography in Relapsing-Remitting Multiple Sclerosis With and Without Prior Optic Neuritis.
Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Xavier Montalban: a pioneer in understanding multiple sclerosis.
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Vitamin D in MS: A vitamin for 4 seasons.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Depression in multiple sclerosis: A long-term longitudinal study.
Contributing factors in multiple sclerosis and the female sex bias.
Effects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation.
Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.
Daclizumab for relapsing remitting multiple sclerosis.
Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis.
Immunological differences between classical phenothypes of multiple sclerosis.
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Factors affecting anxiety in multiple sclerosis.
Enigmatic GPCR Finds a Stimulating Drug.
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.
Origin and differentiation of microglia.
Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders.
Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.

Pages